dual PARP-1/HDAC-1 inhibitors (Hefei University of Technology)

N/A

Report date: 2025/03/18 18:11:59
NME

Base Information

Drug Namedual PARP-1/HDAC-1 inhibitors (Hefei University of Technology)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone deacetylase 1 inhibitorsPoly (ADP-Ribose) polymerase 1 inhibitors
TargetsPoly (ADP-Ribose) polymerase 1Histone deacetylase 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesHefei University Of Technology
China Registration ClassN/A

Develop Information

Active CompaniesHefei University Of Technology
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A